항균제 감수성 시험 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 제품별, 기술별, 용도별, 최종사용자별, 지역별, 경쟁별(2020-2030년)

Antimicrobial Susceptibility Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Technique, By Application, By End User, By Region and Competition, 2020-2030F

US $ 4,500 ￦ 6,286,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며, 텍스트의 Copy&Paste도 불가능합니다.

US $ 5,500 ￦ 7,682,000

PDF and Excel (Multi-User License)

PDF 및 Excel 보고서를 기업의 팀이나 기관에서 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다.

US $ 8,000 ￦ 11,175,000

PDF and Excel (Custom Research License)

PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 및 Excel 이용 범위와 동일합니다. 80시간의 애널리스트 타임이 포함되어 있고 Copy & Paste 가능한 PPT 버전도 제공됩니다. 짧은 Bespoke 리서치 프로젝트 수행에 맞는 라이선스입니다.

한글목차

항균제 감수성 시험(AST) 세계 시장 규모는 2024년 44억 1,000만 달러에서 2030년에는 59억 8,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 5.17%의 CAGR로 성장할 것으로 예상됩니다.

항생제 내성이 전 세계 보건의 시급한 문제로 떠오르면서 정확하고 시기적절한 진단 도구의 필요성이 높아짐에 따라 AST는 임상의가 적절한 항생제 치료를 할 수 있도록 안내하고 치료 실패율을 낮추며 항균제 오남용을 억제하는 데 매우 중요한 역할을 하고 있습니다. 다제내성 감염증의 확산과 항균제 내성(AMR)에 대한 전 세계적인 인식이 높아짐에 따라 신뢰할 수 있는 AST 솔루션에 대한 수요가 증가하고 있습니다. 신속하고 자동화된 진단 시스템의 발전은 특히 병원과 진단 연구소에서 도입이 가속화되고 있습니다. 또한, AI와 머신러닝을 AST 플랫폼에 통합하여 정확도와 효율성을 향상시킴으로써 AST는 개인화된 의료와 정밀의료의 필수적인 요소로 자리 잡고 있습니다.

시장 개요
예측 기간	2026-2030년
시장 규모 : 2024년	44억 1,000만 달러
시장 규모 : 2030년	59억 8,000만 달러
CAGR : 2025-2030년	5.17%
급성장 부문	의약품 개발
최대 시장	북미

시장 촉진요인

감염성 질환 발병률 증가

주요 시장 과제

표준화 및 검증 부족

주요 시장 동향

자동화 및 고처리량 시스템으로의 전환

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 세계의 항균제 감수성 시험 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율과 예측
  • 제품별(수동 테스트(MIC 스트립, 감수성 시험 디스크, 감수성 플레이트), 자동 기기, 소모품 및 미디어)
  • 기술별(자동 AST, E테스트법, 희석법, 디스크 확산법, 기타)
  • 용도별(의약품 개발, 감수성 시험, 기타)
  • 최종사용자별(병원, 진단 연구소, 바이오테크놀러지·제약회사, 기타)
  • 기업별(2024)
  • 지역별
• 시장 맵

제6장 북미의 항균제 감수성 시험 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 북미 : 국가별 분석
  • 미국
  • 멕시코
  • 캐나다

제7장 유럽의 항균제 감수성 시험 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 유럽 : 국가별 분석
  • 프랑스
  • 독일
  • 영국
  • 이탈리아
  • 스페인

제8장 아시아태평양의 항균제 감수성 시험 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 한국
  • 일본
  • 호주

제9장 남미의 항균제 감수성 시험 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 항균제 감수성 시험 시장 전망

• 시장 규모 및 예측
• 시장 점유율과 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향과 발전

• 인수합병
• 제품 출시
• 최근 동향

제13장 Porter's Five Forces 분석

• 업계내 경쟁
• 신규 참여의 가능성
• 공급업체의 능력
• 고객의 능력
• 대체품의 위협

제14장 경쟁 구도

• Bio-Rad Laboratories Inc.
• Merck & Co., Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• bioMerieux SA
• Becton, Dickinson and Company
• ELITech Group SAS
• F. Hoffmann-La Roche Ltd.
• Accelerate Diagnostics, Inc.
• HiMedia Laboratories Private Limited

제15장 전략적 제안

제16장 조사 회사 소개 및 면책사항

ksm

영문 목차

영문목차

The Global Antimicrobial Susceptibility Testing (AST) Market was valued at USD 4.41 billion in 2024 and is projected to reach USD 5.98 billion by 2030, growing at a CAGR of 5.17% during the forecast period. The market is expanding significantly as antibiotic resistance becomes a pressing global health concern, prompting the need for accurate, timely diagnostic tools. AST plays a pivotal role in guiding clinicians toward appropriate antibiotic treatments, reducing therapy failure rates and curbing the misuse of antimicrobial agents. The growing prevalence of multidrug-resistant infections and the increased global awareness around antimicrobial resistance (AMR) have elevated the demand for reliable AST solutions. Advancements in rapid and automated diagnostic systems are accelerating adoption, particularly in hospitals and diagnostic laboratories. Additionally, integration of AI and machine learning into AST platforms is enhancing precision and efficiency, making AST an essential component of personalized and precision medicine.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 4.41 Billion
Market Size 2030	USD 5.98 Billion
CAGR 2025-2030	5.17%
Fastest Growing Segment	Drug Development
Largest Market	North America

Key Market Drivers

Increase in Prevalence of Infectious Diseases

The rising incidence of infectious diseases, including influenza, tuberculosis, pneumonia, and COVID-19, is significantly driving demand for antimicrobial susceptibility testing. As pathogens evolve and resistance increases, AST has become critical for selecting effective treatments and minimizing inappropriate antibiotic usage. For instance, COVID-19 underscored the need for robust diagnostic infrastructure to manage outbreaks and inform treatment protocols. Similarly, pneumonia remains a leading cause of mortality among children globally, particularly in low-income regions. AST helps clinicians identify suitable antimicrobials, thereby improving patient outcomes and reducing AMR risks. The growing dependence on AST for both routine and emergent infectious disease management continues to fuel market growth.

Key Market Challenges

Lack of Standardization and Validation

A major obstacle in the AST market is the absence of standardized procedures and validation protocols across different testing platforms and laboratories. The variation in testing methods can lead to inconsistent results, complicating clinical interpretation and undermining treatment efficacy. Without uniform guidelines, healthcare providers may struggle to compare susceptibility data across institutions or regions. The validation of new AST technologies is also resource-intensive, involving extensive trials to meet regulatory requirements. In developing regions, limited infrastructure and training further exacerbate the issue. These inconsistencies can delay adoption and hinder efforts to combat antimicrobial resistance effectively. Establishing global standards and robust validation processes is essential to address this challenge.

Key Market Trends

Shift Towards Automated and High-Throughput Systems

The global AST market is increasingly embracing automation and high-throughput platforms to meet rising diagnostic demand. Automated AST systems offer faster turnaround times, higher accuracy, and improved workflow efficiency, making them ideal for high-volume clinical settings. These systems reduce human error and enable large-scale sample processing, essential for timely identification of effective therapies. Integration with laboratory information systems (LIS) allows seamless data management and reporting. High-throughput capabilities are particularly critical as healthcare facilities face increasing caseloads due to infectious diseases and AMR. This trend toward automation is reshaping the diagnostic landscape, providing scalable, reliable solutions for modern healthcare environments.

Key Market Players

• Bio-Rad Laboratories Inc.
• Merck & Co., Inc.
• Thermo Fisher Scientific Inc.
• Danaher Corporation
• bioMerieux SA
• Becton, Dickinson and Company
• ELITech Group SAS
• F. Hoffmann-La Roche Ltd.
• Accelerate Diagnostics, Inc.
• HiMedia Laboratories Private Limited

Report Scope:

In this report, the Global Antimicrobial Susceptibility Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Antimicrobial Susceptibility Testing Market, By Product:

• Manual Tests
  • MIC Strips
  • Susceptibility Testing Disks
  • Susceptibility Plates
• Automated Instruments
• Consumables & Media

Antimicrobial Susceptibility Testing Market, By Technique:

• Automated AST
• Etest Method
• Dilution
• Disk Diffusion
• Others

Antimicrobial Susceptibility Testing Market, By Application:

• Drug Development
• Susceptibility Testing
• Others

Antimicrobial Susceptibility Testing Market, By End User:

• Hospitals
• Diagnostic Laboratories
• Biotechnology & Pharmaceutical Companies
• Others

Antimicrobial Susceptibility Testing Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Antimicrobial Susceptibility Testing Market.

Available Customizations:

Global Antimicrobial Susceptibility Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Antimicrobial Susceptibility Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Manual Tests {MIC Strips, Susceptibility Testing Disks, Susceptibility Plates}, Automated Instruments, Consumables & Media)
  • 5.2.2. By Technique (Automated AST, Etest Method, Dilution, Disk Diffusion, Others)
  • 5.2.3. By Application (Drug Development, Susceptibility Testing, Others)
  • 5.2.4. By End User (Hospitals, Diagnostic Laboratories, Biotechnology & Pharmaceutical Companies, Others)
  • 5.2.5. By Company (2024)
  • 5.2.6. By Region
• 5.3. Market Map

6. North America Antimicrobial Susceptibility Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Technique
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Antimicrobial Susceptibility Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Technique
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Mexico Antimicrobial Susceptibility Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Technique
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Canada Antimicrobial Susceptibility Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Technique
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Antimicrobial Susceptibility Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Technique
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Technique
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. Germany Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Technique
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Technique
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Technique
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Antimicrobial Susceptibility Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Technique
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia-Pacific Antimicrobial Susceptibility Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Technique
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Technique
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Technique
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. South Korea Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Technique
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. Japan Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Technique
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Antimicrobial Susceptibility Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Technique
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. South America Antimicrobial Susceptibility Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Technique
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Antimicrobial Susceptibility Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Technique
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. Argentina Antimicrobial Susceptibility Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Technique
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. Colombia Antimicrobial Susceptibility Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Technique
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. Middle East and Africa Antimicrobial Susceptibility Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Technique
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Antimicrobial Susceptibility Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Technique
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Saudi Arabia Antimicrobial Susceptibility Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Technique
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. UAE Antimicrobial Susceptibility Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Technique
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Bio-Rad Laboratories Inc.
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Products & Services
  • 14.1.4. Financials (As Reported)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. Merck & Co., Inc.
• 14.3. Thermo Fisher Scientific Inc.
• 14.4. Danaher Corporation
• 14.5. bioMerieux SA
• 14.6. Becton, Dickinson and Company
• 14.7. ELITech Group SAS
• 14.8. F. Hoffmann-La Roche Ltd.
• 14.9. Accelerate Diagnostics, Inc.
• 14.10. HiMedia Laboratories Private Limited

15. Strategic Recommendations

16. About Us & Disclaimer

관련자료